LOGO
LOGO

Quick Facts

Veradermics Stock Falls 8% After Reporting Wider Loss In Q4, FY25

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News   | Join Us

Shares of Veradermics, Incorporated (MANE) are moving down about 8 percent on Monday morning trading after reporting a wider loss in the fourth quarter and full year financial results.

The company's stock is currently trading at $60.24, down 8.08 percent or $5.29, over the previous close of $65.53 on the New York Stock Exchange. It has traded between $32.00 and $66.07 in the past one year.

For the quarter, the company reported a net loss of $21.8 million compared to last year's $5.7 million. Meanwhile, the company's loss for the full year stood at $69.9 million compared to $26.5 million in the previous year.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Global Economics Weekly Update: May 11 – May 15, 2026

May 15, 2026 15:25 ET
Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.

Latest Updates on COVID-19